Similar Articles
Methotrexate and Leflunomide in the Treatment of Rheumatoid Arthritis
Hatice Bodur
Treatment with 100 Mg Weekly Leflunomide in Rheumatoid Arthritis-An Open Study
Halil Koyuncu, Neval Bozok, Seçil Yalgın, Fatma Kumbasar, Haluk Aksoy
Evaluation of Effectiveness of Leflunomide in the Treatment of Rheumatoid Arthritis
Filiz Eser, Hatice Bodur, Lale Akbulut Aktekin , Ümit Seçkin
Assessment of Radiologic Damage by Larsen Score in Adults With Juvenile Idiopathic Arthritis
Eda Gürçay, Serdil Yüzer , Emel Ekşioğlu, Ajda Bal, Aytül Çakcı
Long Term Use of Leflunomide as a Cause of Severe Diarrhea?
Zafer Günendi, Esin Benli, Feride Göğüş, Fatma Atalay
DOI: 10.46497/tjr.2010.08
The Clinical Value of Serum Anti-Cyclic Citrullinated Peptide Antibodies for Juvenile Idiopathic Arthritis
Xiaolan HUANG, Zheng XU, Fengqi WU, Xiaodai CUI, Xiaofeng LI, Xianzi CONG, Jianglin ZHANG
DOI: 10.5606/tjr.2012.040
The Reported Adverse Effects Related to Biological Agents Used for the Treatment of Rheumatic Diseases in Turkey
Erkan KILIÇ, Gamze KILIÇ, Özgür AKGÜL, Gürkan AKGÖL, Salih ÖZGÖÇMEN
DOI: 10.5606/tjr.2013.3052
The Off-Label Use of Rituximab for the Management of Inflammatory Disorders: American University of Beirut Medical Center Experience
Dana HARB, Hiba MOUKADEM, Rabih NAYFE, Ali MEHDI, Abdel Fattah MASRI, Ziad SALEM, Ali TAHER, Imad UTHMAN
DOI: 10.5606/ArchRheumatol.2014.3855
Efficacy of Tumor Necrosis Factor Inhibitors in Patients With Ankylosing Spondylitis
Deniz DÜLGEROĞLU ERDOĞDU, Ajda BAL, Özgür KARAAHMET, Sibel ERKOÇ, Tuğba YALÇIN, Aytül ÇAKCI
DOI: 10.5606/ArchRheumatol.2014.4045
Evaluation of Childhood Health Assessment Questionnaire in Juvenile Idiopathic Arthritis: A Single Center Experience From Turkey
Duygu GÜMÜŞ, Özge BAŞARAN, Nilgün ÇAKAR, Nermin UNCU, Banu ÇELİKEL ACAR
DOI: 10.5606/ArchRheumatol.2015.5130
A Rare Kind of Lymphoma in a Patient on Treatment With Two Different Biological Agents
Inesa ARSTIKYTE, Irena BUTRIMIENE, Agne PETRULIONIENE, Algirdas VENALIS
DOI: 10.5606/ArchRheumatol.2015.4383
Outcome of Juvenile Idiopathic Arthritis Associated Uveitis in Two Disease Subtypes
Dragana LAZAREVIĆ, Ivana NIKOLIĆ, Marija RATKOVIĆ-JANKOVIĆ, Jelena VOJINOVIĆ
DOI: 10.5606/ArchRheumatol.2017.6060
Occurrence of Ulcerative Colitis in a Patient With Adult-Onset Still's Disease: Coincidence or Correlated
Yun Jung CHOI, Wan-hee YOO
DOI: 10.5606/ArchRheumatol.2017.6182
Interleukin-17A Levels Increase in Serum of Children With Juvenile Idiopathic Arthritis
Gordana VIJATOV-DJURIC, Aleksandra DORONJSKI, Igor MITIC, Snezana BRKIC, Nenad BARISIC
DOI: 10.5606/ArchRheumatol.2017.6067
The Assessment of Serum Endocan Levels in Children With Juvenile Idiopathic Arthritis
Yasin YILMAZ, Rana BERRU DURMUŞ, Başak SARAÇOĞLU, Sezgin ŞAHİN, Amra ADROVIC, Kenan BARUT, Sevda ÖZEL YILDIZ, Özgür KASAPÇOPUR, Rukiye EKER ÖMEROĞLU
DOI: 10.5606/ArchRheumatol.2018.6528
Immunoglobulin G4-Related Disease Presented as Recurrent Otitis Media and Mixed Hearing Loss Treated With Cyclophosphamide and Rituximab: A Case Report
Shao SAN, Chia-der LIN, Sheng-ta TSAI, Chao-chun LIN, Po-chang WU
DOI: 10.5606/ArchRheumatol.2019.7178
Etiologic Spectrum and Follow-Up Results of Noninfectious Uveitis in Children: A Single Referral Center Experience
Mustafa ÇAKAN, Dilbade YILDIZ EKİNCİ, Şerife GÜL KARADAG, Nuray AKTAY AYAZ
DOI: 10.5606/ArchRheumatol.2019.7253
Efficacy of Rituximab for Refractory Pyoderma Gangrenosum-Like Ulcers in Granulomatosis With Polyangiitis Associated to Antiphospholipid Antibodies
Julia RIERA, Jorge MUSURUANA, Cecilia COSTA, Javier CAVALLASCA
DOI: 10.46497/ArchRheumatol.2020.7498
Biologics in juvenile idiopathic arthritis-main advantages and major challenges: A narrative review
Amra ADROVIC, Mehmet YILDIZ, Oya KÖKER, Sezgin ŞAHİN, Kenan BARUT, Özgür KASAPÇOPUR
DOI: 10.46497/ArchRheumatol.2021.7953
The use of anti-interleukin-1 agents and tumor necrosis factor‐alpha inhibitors in renal transplant recipients
Veli Yazısız, Vural Taner Yılmaz, İsmail Uçar, Özgür Dandin, Bengisu Aslan, Funda Erbasan, Hüseyin Koçak, Mustafa Ender Terzioğlu
DOI: 10.46497/ArchRheumatol.2021.8500